We are live on ! Find out more
MDXG icon

MiMedx Group

199 hedge funds and large institutions have $786M invested in MiMedx Group in 2023 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 57 increasing their positions, 65 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

243% more call options, than puts

Call options by funds: $2.1M | Put options by funds: $614K

119% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 16

90% more capital invested

Capital invested by funds: $415M → $786M (+$372M)

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

28.08% more ownership

Funds ownership: 48.97%77.05% (+28%)

8% more funds holding

Funds holding: 185199 (+14)

12% less repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 65

Holders
199
Holders Change
+14
Holders Change %
+7.57%
% of All Funds
2.9%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
35
Increased
57
Reduced
65
Closed
16
Calls
$2.1M
Puts
$614K
Net Calls
+$1.49M
Net Calls Change
+$724K
Name Holding Trade Value Shares
Change
Change in
Stake
EWM
1
Essex Woodlands Management
Texas
$247M +$206M +28,195,249 New
BlackRock
2
BlackRock
New York
$83.6M +$4.36M +595,624 +7%
Vanguard Group
3
Vanguard Group
Pennsylvania
$57.6M +$953K +130,099 +2%
State Street
4
State Street
Massachusetts
$35.9M -$296K -40,377 -1%
PCMI
5
Paradigm Capital Management Inc
New York
$30.1M -$366K -50,000 -1%
Morgan Stanley
6
Morgan Stanley
New York
$27.8M +$11.7M +1,597,853 +101%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$22.3M +$804K +109,838 +5%
CC
8
Cannell Capital
Wyoming
$21.8M +$1.52M +207,207 +9%
RB
9
Richmond Brothers
Michigan
$12.3M -$564K -76,980 -5%
DSCM
10
Divisadero Street Capital Management
Florida
$11.3M +$8.14M +1,112,161 +618%
Renaissance Technologies
11
Renaissance Technologies
New York
$11M +$1.24M +168,700 +16%
Charles Schwab
12
Charles Schwab
California
$9.95M +$423K +57,704 +5%
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
$9.46M +$1.86M +253,737 +31%
Northern Trust
14
Northern Trust
Illinois
$9.44M +$43K +5,870 +0.5%
Prudential Financial
15
Prudential Financial
New Jersey
$8.23M +$141K +19,210 +2%
Arrowstreet Capital
16
Arrowstreet Capital
Massachusetts
$8.09M +$1.86M +254,032 +38%
RA
17
Royce & Associates
New York
$7.56M -$40.3K -5,500 -0.6%
Federated Hermes
18
Federated Hermes
Pennsylvania
$7.08M -$258K -35,247 -4%
Two Sigma Advisers
19
Two Sigma Advisers
New York
$6.32M -$182K -24,900 -3%
Two Sigma Investments
20
Two Sigma Investments
New York
$5.44M -$72.8K -9,948 -2%
PI
21
Putnam Investments
Massachusetts
$4.97M -$727K -99,334 -15%
Bank of America
22
Bank of America
North Carolina
$4.79M -$512K -69,878 -11%
Russell Investments Group
23
Russell Investments Group
United Kingdom
$4.6M +$3.62M +493,759 +1,578%
Norges Bank
24
Norges Bank
Norway
$4.29M -$108K -14,700 -3%
Goldman Sachs
25
Goldman Sachs
New York
$4.26M +$531K +72,496 +18%

MDXG Hedge Fund Activity: Q4 2023 in Review

199 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in MiMedx Group (MDXG) for Q4 2023, worth a combined $786M — up 90% from $415M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new MDXG positions and 16 closed out — a net gain of 19 holders — while 57 added to existing stakes and 65 trimmed.

The largest buyer was Essex Woodlands Management, opening a new position worth an estimated $206M. The largest seller was Kanen Wealth Management, exiting entirely with an estimated $6.73M sold.

  • 199 institutional investors held MiMedx Group (MDXG) as of Q4 2023, up from 185 in Q3 2023.
  • Funds reported $786M of MiMedx Group stock for Q4 2023, up 90% quarter-over-quarter.
  • 35 funds opened new MiMedx Group positions in Q4 2023 and 16 closed out, a net change of +19 holders.
  • The largest MiMedx Group buyer in Q4 2023 was Essex Woodlands Management, an estimated $206M added.
  • The largest MiMedx Group seller in Q4 2023 was Kanen Wealth Management, an estimated $6.73M sold.

Based on aggregated 13F filings for Q4 2023.